NCT05745051 is a NA clinical trial of CVAid Flow in Stroke, sponsored by Cvaid Medical.

Who is sponsoring NCT05745051?

NCT05745051 is sponsored by Cvaid Medical.

What drugs are being tested in NCT05745051?

Interventions in NCT05745051: CVAid Flow.

What condition does NCT05745051 study?

NCT05745051 studies Stroke, Stroke, Acute, Stroke, Ischemic, Stroke, Cardiovascular, Stroke Hemorrhagic.

Is NCT05745051 still recruiting?

NCT05745051 is currently status unknown. Last updated 30 August 2023.

Last reviewed 2023-08-30 · How we verify

NCT05745051

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Safety and Effectiveness of CVA-FLOW Software Device for Acute Ischemic Stroke

Status unknown NA Last updated 30 August 2023

What this trial tests

NA trial testing CVAid Flow in Stroke in 100 participants. Status unknown.

Timeline

8 November 2022

Primary endpoint
30 October 2023

30 November 2023

Quick facts

Lead sponsor	Cvaid Medical
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	100
Start date	8 November 2022
Primary completion	30 October 2023
Estimated completion	30 November 2023
Sites	1 location across Israel

Drugs / interventions tested

CVAid Flow

Conditions studied

Stroke — all drugs for Stroke →
Stroke, Acute — all drugs for Stroke, Acute →
Stroke, Ischemic — all drugs for Stroke, Ischemic →
Stroke, Cardiovascular — all drugs for Stroke, Cardiovascular →

Sponsor

Cvaid Medical

Who can join

18 and older, any sex, with Stroke or Stroke, Acute. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to demonstrate the effectiveness and safety of CVA-FLOW, a digital health AI based Telestroke system developed by CVAID Ltd. Company aims to assist certified medical staff to triage acute ischemic stroke patients using dedicated algorithms in order to support application for market approval for CVA-FLOW device.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
NCT07356011 — Exoskeleton for Balance · NA · recruiting
NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in · NA · recruiting
NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients · NA · recruiting

Other Cvaid Medical trials

Trials by the same sponsor.

NCT06101004 — A Multi-center, Non-interventional Prospective Clinical Trial to Evaluate the Safety and Effectiveness of CVA-FLOW · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05745051 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cvaid Medical
Last refreshed: 30 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05745051.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing